Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for inflammation in non-cystic fibrosis bronchiectasis with Pseudomonas aeruginosa
2010-022042-24Phase 4Completed
- Sponsor
- NHS Lothian
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bronchiectasis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in cough severity and impact (Leicester Cough Questionnaire). Started Oct 2010; status: completed.
02
Drugs
atorvastatin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2010-022042-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022042-24.